The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis
Open accessAbstract
Hemangiomas are benign tumors of the vascular endothelium and are the most common tumors of infancy. These tumors are characterized by an initial phase of rapid proliferation, which is followed, in most cases, by spontaneous involution. Although most lesions resolve without complication, there are some cases in which hemangiomas can be life threatening when occurring near a vital structure. Treatment for these aggressive tumors represents an unmet clinical need. In addition, this characteristic progression of hemangiomas through distinct phases provides a unique opportunity for studying endothelial cell biology and angiogenesis. Using DNA microarrays representing approximately 10,000 human genes, we identified insulin-like growth factor 2 (IGF-2) as a potentially important regulator of hemangioma growth. IGF-2 was highly expressed during the proliferative phase and substantially decreased during involution. This finding was confirmed at the message level by quantitative reverse transcription–PCR and at the protein level by immunohistochemistry. IGF-2 protein was localized primarily to tumor vessels or vascular channels. Using a human hemangioma explant model, we show that IGF-2 promotes sprouting from intact hemangioma tissue. In addition, several angiogenesis-related factors, including integrins αvβ3 and α5β1, are present in proliferating hemangiomas. During the involuting phase, an increase in several IFN-induced genes was observed. These studies identify potential regulators of hemangioma growth and involution and provide a foundation on which to build further mechanistic investigations into angiogenesis, using hemangiomas as a model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
Regulation of cell surface GLUT1, GLUT3, and GLUT4 by insulin and IGF‐I in L6 myotubes
Wilson, C. M., Mitsumoto, Y., Maher, F., & Klip, A. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00589-2 · Cited by 73
Cited by
Bruckner, A. L., & Frieden, I. J. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.200 · Cited by 381
ISSVA Classification of Vascular Anomalies and Molecular Biology
Kunimoto, K., Yamamoto, Y., & Jinnin, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042358 · Cited by 309
Diagnosis and Management of Infantile Hemangioma
Darrow, D. H., Greene, A. K., Mancini, A. J., Nopper, A. J., the SECTION ON DERMATOLOGY, S. O. O. A. N. S., Antaya, R. J., Cohen, B., Drolet, B. A., Fay, A., Fishman, S. J., et al. (2015) · Pediatrics · doi:10.1542/peds.2015-2485 · Cited by 293
Self-citationRitter, M. R., Banin, E., Moreno, S. K., Aguilar, E., Dorrell, M. I., & Friedlander, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29683 · Cited by 275
Self-citationCorticosteroid Suppression of VEGF-A in Infantile Hemangioma-Derived Stem Cells
Greenberger, S., Boscolo, E., Adini, I., Mulliken, J. B., & Bischoff, J. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0903036 · Cited by 275
Metadata
- Authors
- Ritter, M. R., Dorrell, M. I., Edmonds, J., Friedlander, S. F., & Friedlander, M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-05-28
- Volume
- 99
- Issue
- 11
- Pages
- 7455-7460
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2121587783
- Cited by
- 172
- References
- 2
- FWCI
- 10.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis. https://app.cochat.ai/papers/10.1073/pnas.102185799
- The paper
- Ritter, M. R., Dorrell, M. I., Edmonds, J., Friedlander, S. F., & Friedlander, M. (2002). Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.102185799
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.